Severe opioid withdrawal due to misuse of new combined morphine and naltrexone product (Embeda). 2010

David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson

UI MeSH Term Description Entries
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
March 2010, The Medical letter on drugs and therapeutics,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
January 1991, Revista espanola de anestesiologia y reanimacion,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
January 2012, Journal of opioid management,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
January 2020, Indian journal of psychiatry,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
May 2011, Expert opinion on pharmacotherapy,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
October 2019, CJEM,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
January 2017, Journal of opioid management,
David H Jang, and John C Rohe, and Robert S Hoffman, and Lewis S Nelson
January 2003, Journal of paediatrics and child health,
Copied contents to your clipboard!